1995
DOI: 10.1056/nejm199508103330603
|View full text |Cite
|
Sign up to set email alerts
|

Time of Onset of Non-Insulin-Dependent Diabetes Mellitus and Genetic Variation in the β3-Adrenergic–Receptor Gene

Abstract: Pima subjects homozygous for the Trp64Arg beta 3-adrenergic-receptor mutation have an earlier onset of NIDDM and tend to have a lower resting metabolic rate. This mutation may accelerate the onset of NIDDM by altering the balance of energy metabolism in visceral adipose tissue.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

23
410
7
18

Year Published

1997
1997
2009
2009

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 585 publications
(458 citation statements)
references
References 29 publications
23
410
7
18
Order By: Relevance
“…Thus, it can be inferred that these genetic variants and modifiable risk factors may interact in a multiplicative manner to establish a vicious cycle involving obesity, dyslipidaemia, hypertension and renal dysfunction. The interaction term of lipid × ADRB on obesity, especially in the highrisk model, is consistent with known risk associations of genetic variants of ADRB2 and ADRB3 with diabetes, obesity, fatty liver, dyslipidaemia, hypertension and reduced metabolic rate in multiple populations [42][43][44][45][46]. Since sympathetic adrenergic activity is a major determinant of lipolysis and energy metabolism, it is plausible that a combination of genetic factors that promote lipogenesis and/or reduce lipolysis may facilitate energy storage during times of deprivation but predispose to obesity during times of plenty [47].…”
Section: Effects Of Genotypes and Phenotypes On Renal Functionsupporting
confidence: 79%
“…Thus, it can be inferred that these genetic variants and modifiable risk factors may interact in a multiplicative manner to establish a vicious cycle involving obesity, dyslipidaemia, hypertension and renal dysfunction. The interaction term of lipid × ADRB on obesity, especially in the highrisk model, is consistent with known risk associations of genetic variants of ADRB2 and ADRB3 with diabetes, obesity, fatty liver, dyslipidaemia, hypertension and reduced metabolic rate in multiple populations [42][43][44][45][46]. Since sympathetic adrenergic activity is a major determinant of lipolysis and energy metabolism, it is plausible that a combination of genetic factors that promote lipogenesis and/or reduce lipolysis may facilitate energy storage during times of deprivation but predispose to obesity during times of plenty [47].…”
Section: Effects Of Genotypes and Phenotypes On Renal Functionsupporting
confidence: 79%
“…24 In previous epidemiologic studies, the association between the ADRB3 variant and obesity-related phenotypes has been investigated among individuals from several racial/ ethnic groups and nationalities, including Caucasians, 13 Japanese, 12,25,26 Pima Indians, 24 Mexican Americans, 14 African Americans 27,28 and Jamaicans. 29 Previous studies of white or Japanese populations found the variant allele of the ADRB3 receptor to be associated with elevated measures of obesity, 13 whereas two previous studies of African Americans reported associations with the wild-type receptor.…”
Section: Adrb3 and Obesity R Mckean-cowdin Et Almentioning
confidence: 99%
“…31 The tryptophan-toarginine substitution at codon 64 of ADRB3 was initially reported in 1995. 13,15,24 The substitution is located in the first coding exon, at the junction of the first transmembrain domain and the first intracellular loop of the receptor. 32,33 The impact of the missense change is not known; it has been suggested that the substitution could impact receptorprotein folding or alter functional properties such as ligand binding or receptor activation.…”
Section: Adrb3 and Obesity R Mckean-cowdin Et Almentioning
confidence: 99%
“…In most cases, the clinical expression of the disease can be prevented by dietary and lifestyle modification [1]. On the other hand, the genetic base of Type II diabetes is very heterogeneous and has been related to various genetic mutations that codify proteins linked to glucose and insulin metabolism, such as the insulin receptor [2], the insulin receptor substrate-1 [3], the Rad protein [4], the glycogen synthase [5] and the β-3-adrenergic receptor [6]. However, the genetic background of insulin resistance and Type II diabetes is more complex and it can also involve other genes seemingly unrelated to carbohydrate metabolism.…”
mentioning
confidence: 99%